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Abstract

The treatment of chronic diseases with multiple medications as recommended by
advancements in healthcare guidelines has become a standard of medical practice. The
promotion of such guidelines has proven to be beneficial and enhance quality of life in our
geriatric populations. The clinical trials that produce such guidelines often exclude older adults
with comorbid conditions thus making them ungeneralizable to this population. This lack of
quality evidence places patients and providers at risk for potentially inappropriate prescribing.
Explicit tools such as the STOPP/START criteria have been developed to help guide providers in
making safe choices for elderly patients. The purpose of this paper is to explain the
STOPP/START criteria and determine if it is effective in reducing potentially inappropriate
prescribing in the elderly. A literature review will also outline the impact that using such a tool
has on health outcomes of this population as well as comparing the tool to the more widely
known Beer’s criteria. Finally, a case report will be analyzed using the STOPP/START criteria
detailing the benefits of using explicit criteria tools to help guide provider’s prescription
practices.
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Reducing Potentially Inappropriate Prescribing in Geriatrics using the STOPP/START Tool
Background
The past century has witnessed a major shift from the leading causes of death for all age
groups from infectious disease and acute illnesses to chronic conditions. In fact, two out of three
older Americans have multiple chronic conditions (Centers for Disease Control and Prevention
(CDC), 2013). Furthermore, patients aged 80 and above suffer from a mean number of 3.3
chronic medical conditions and on average three drugs are prescribed per disease (Topinkova,
Baeyens, Michel, & Lang, 2012). The promotion of the use of clinical guidelines which
frequently advocates more than one drug to manage common chronic conditions has become the
standard of medical practice. These guidelines are widely accepted as beneficial as they are
supported by a substantial amount of evidence (Cadogan et al., 2015; Patterson et al., 2014).
Although the clinical trials that are the base of such guidelines are evidence based, they often
exclude older adults and focus only on a specific disease. Thus, the use of guidelines in the
elderly with multiple chronic conditions may lead to potentially inappropriate prescribing by the
provider (Corsonello et al., 2012).
Potentially inappropriate prescribing (PIP) is strongly associated with overprescribing but
it is also associated with misprescribing as well as underprescribing. Potentially inappropriate
prescribing has been correlated with increases in morbidity, adverse drug events, hospitalization,
and mortality (Cahir et al., 2010; Cooper et al., 2015). The phenomenon of PIP is extremely
common and several validated explicit criteria tools have been developed to assist providers in
reducing the frequency of PIP occurrences in the geriatric population. Explicit tools are
criterion based and developed from a published review, expert opinion, and consensus
techniques. The first widely used tool recognized was the Beers criteria. Although widely
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accepted, the Beers criteria do not address many important aspects of PIP such as drug to drug
interactions, therapeutic duplication, inappropriate duration of therapy, and underprescribing of
clinically indicated medications. Furthermore, the Beer’s criteria can be difficult and time
consuming in daily practice as they are not presented in any particular order or structure
(Corsonello et al., 2012; P. Gallagher & O'Mahony, 2008).
The perceived deficiencies of the Beer’s criteria lead to the development of the Screening
Tool of Older Persons’ Prescriptions (STOPP) and the Screening Tool to Alert Doctors to Right
Treatment (START). The STOPP/START criteria have become widely used in Europe and have
been found to be successfully applied to both research and clinical environments. A multitude of
studies have shown its superiority over the Beer’s criteria (O'Mahony et al., 2015). Thus, this
text means to provide an overview of this new widely used tool and its implications in practice in
correlation with a presented case study.
Case Report
History of Present Illness
Mrs. E.S. is an 86-year-old female who presents to the clinic today for a hospital follow
up visit. She was hospitalized for three days with a diagnosis of a urinary tract infection. E.S.
was discharged on Nitrofurantoin ER 100 mg orally twice per day, she has three days left of this
course of treatment. She has a presenting complaint of “feeling more tired than usual” with
further reports of “feeling dizzy” throughout the day but especially in the early morning after
positional changes. E.S. states that these symptoms of fatigue and dizziness began after her
discharge from the hospital which was four days ago and denies having these symptoms prior to
her hospitalization. E.S. reports that her symptoms of dizziness are relieved with “sitting down
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and resting.” She also reports that she has been less active since her hospital discharge due to
her feelings of fatigue.
History
E.S. has an unknown family history and no known allergies. She lives at an assisted
living center where nursing staff assist her with medication administration and occasionally
meals. Per patient report, she is able to accomplish all activities of daily living independently.
She denies any surgical history. Per record review she has a history of dementia, diabetes,
chronic obstructive pulmonary disease (COPD), anemia, hypertension, depression, and
neuropathy. Her current medication list is as follows, Donepezil 5 mg orally daily, Fluticasone
proprionate and salmeterol 250/50 one puff twice per day, Losartan 50 mg orally daily,
Metoprolol 50 mg orally twice per day, Gabapentin 300 mg orally three times per day,
Paroxetine 20 mg orally daily, Quetiapine 200 mg orally twice per day, Insulin Glargine 30 units
subcutaneous injection every night at bedtime, Multivitamin orally daily, Iron Sulfate 325 mg
orally daily, and Nitrofurantoin ER 100 mg twice per day with three days left of treatment
course. History was confirmed with patient at the time of interview.
Review of Systems
E.S. denies fever or weakness. Reports “feeling tired all day long” which has been
present since hospital discharge four days ago. Reports feeling dizzy in the morning with
position changes. Denies hearing loss, pain or discharge. Denies loss of balance. Denies any
recent cough or difficulty breathing. Denies chest pain, palpitations, dyspnea, or orthopnea.
Denies any edema. Denies ever completing an echocardiogram or having a history or heart
arrhythmias. Denies dysphagia, nausea, or vomiting. Denies abdominal or pelvic pain. Denies
constipation or diarrhea as well as black or tarry stools. Denies change in diet or fluid intake.
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Reports drinking one to two 750 ml of water per day. E.S. reports that she monitors her blood
glucose twice per week and that her blood glucose levels are “between 110-130.” Denies urinary
frequency, urgency, dysuria, or hematuria. Denies any gait abnormalities, joint pain, or stiffness.
Denies headaches, lightheadedness, vertigo, syncope, seizures, numbness, gait instability, or
falls. No reports of sadness or worry. Reports good energy and good mood.
Physical Exam
E.S. is well groomed 86-year-old female appearing her stated age. She appears without
any apparent distress. She is alert, oriented to person, place, and time. Mood is pleasant.
Speech is fluent, words are clear. Abstract thinking, attention, comprehension, vocabulary, and
judgement are appropriate and intact. E.S. is determined to be an accurate reporter of health and
history. Vital signs reveal a blood pressure of 88/40, pulse of 50, respirations 24, and a
temperature or 98.6 degrees Fahrenheit.
Head, ears, eyes, nose, and throat exam reveals a normocephalic head without masses or
lesions. Full distribution of hair on scalp. Eyebrows are full. Facial expressions relaxed and
symmetric without tics or drooping. Lids are free from redness, scaling, or lesions. Sclera are
without hemorrhage or jaundice. Pupils are equal in size and react equally to light. External
auditory canals have minimal cerumen impaction. No erythema, edema, or drainage noted.
Tympanic membrane pearly grey in color with cone of light reflection. Bony landmarks
identified. Nose midline without deviation. Oral mucosa pink, moist, and intact. Neck supple,
symmetric, midline without torticollis. Trachea midline. Carotid upstrokes are strong without
bruits. No cervical lymphadenopathy appreciated. Thyroid smooth without nodules.
Cardiac and respiratory exams were negative. Findings included easy and regular
respirations. Skin without cyanosis. Breath sounds clear and vesicular to auscultation
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throughout all lung fields. No rhonchi, wheezes, or stridor appreciated. No jugular venous
distention noted. Normal S1 and S2 sounds heard without murmurs, rubs, or gallops. Rhythm
normal but bradycardia noted. Carotid, radial, and dorsalis pedis pulses two plus bilaterally
without bruits. No edema appreciated, bilateral compression stockings in place.
Abdominal and neurological exams are negative. Findings include an abdomen without
distention or ascites. No tenderness to light or deep palpation. Abdomen soft with normoactive
bowel sounds in all four quadrants. Cerebellar functions intact as evidenced by smooth and
coordinated rapid alternating movements in bilateral upper extremities. Coordinated heal to shin
movements. Gait steady and without difficulty.
Laboratory Exam
To summarize the patient’s pertinent positives, she is noted to having complaints of
dizziness and fatigue. She has hypotensive blood pressure at 88/40 with bradycardia at 50 beats
per minutes (bpm). Furthermore, she reports feelings of dizziness with position changes which
would lead to a suspicion of orthostatic hypotension. Differential diagnosis includes primary vs
orthostatic hypotension, dehydration, ongoing urinary tract infection, anemia, bradycardia,
hypothyroidism, and hypoglycemia. Thus laboratory data was ordered as follows, basic
metabolic panel (BMP), complete blood count (CBC), and a thyroid stimulating hormone (TSH).
All of the aforementioned serum laboratory work up was within normal limits. An
electrocardiogram (EKG) was ordered which revealed sinus bradycardia.
Assessment and Plan
E.S. was diagnosed with hypotension and sinus bradycardia. Treatment of patient’s
hypotension and bradycardia was to reduce her Metoprolol dose to 25 mg twice per day. E.S.
was thoroughly educated on measures to reduce orthostatic hypotension which included slow
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position changes and an increase in fluid intake. E.S. was also instructed to continue to wear
compression stockings during day time hours. Patient has been instructed to monitor blood
pressure every morning and evening for the next two weeks and return to the clinic for a follow
up appointment with documented blood pressure readings. Patient also agrees to return to clinic
for worsening or change in symptoms. E.S. verbalized understanding.
Literature Review
Prescribing for the older population can become a daunting task. As stated previously,
evidence based guidelines have become a staple in the process of treating long term medical
conditions but the studies of which these guidelines are based often exclude older individuals
with comorbid conditions, thus they may not be generalizable to this specific population
(Corsonello et al., 2012). Providers also need to recognize age related changes that affect drug
pharmacokinetics and pharmacodynamics which often lead to adverse health outcomes
(Gallagher & O'Mahony, 2008). To assist in proper prescribing, several explicit criteria tools
have been developed. The Beer’s criteria is the first and most widely used tool of this kind but
has been found to be deficient in identifying common concerns such as drug to drug interactions,
therapeutic duplication, inappropriate duration of therapy, and underprescribing of clinically
indicated medications, thus a new STOPP/START criteria tool was developed. The
STOPP/START tool has proven to be not only more clinically applicable but superior in many
areas when compared to the Beer’s criteria (Corsonello et al., 2012; Gallagher & O'Mahony,
2008; Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).
The aforementioned case study detailed a patient experiencing symptoms of dizziness
and fatigue with findings of hypotension and bradycardia that could be directly correlated with a
prescribed medication (Metoprolol). The case emphasizes the need to complete medication
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reviews in order to reduce not only polypharmacy but the incidents of adverse drug reactions
(ADR) and PIP. The literature review that follows will detail the STOPP/START criteria tool
and its impact on reducing PIP and healthcare outcomes. There will also be a comparison with
the widely used Beer’s criteria. Finally, the STOPP/START tool will be used to evaluate the
outlined case report.
Overview of the STOPP/START Criteria Tool
The STOPP/START criteria was a European initiative which was led by geriatricians
from Ireland and the United Kingdom. The development was promoted by the European Union
Geriatric Medicine Society with its first publication in 2008 and a subsequent version two being
released in 2014 (Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014). The tool is based on evidence and
was validated by a panel of 18 experts in geriatric pharmacotherapy using a Delphi consensus
technique (Gallagher & O'Mahony, 2008). The criteria was developed as the Beer’s criteria had
limited value in Europe due to the fact that several drugs on the Beer’s criteria were no longer
available in most European countries. There was also identification that the Beer’s criteria failed
to address drug-drug interactions, drug-disease interactions, drug class duplications, and failure
to include criteria related to underprescribing. The Beer’s criteria was also thought to be difficult
to utilize in everyday clinical practice due to its lack user friendly organization (Hill-Taylor et
al., 2013).
Both the STOPP and START portions of the tool are organized according to
physiological system which enhance their usability. To enhance their transferability to different
countries with different formularies, medications are listed per class as opposed to specific drugs
(Hill-Taylor et al., 2013). The STOPP criteria was developed to identify medications that are
potentially unnecessary through consideration of drug-drug and drug-disease interactions as well
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as drug dose and duration (Cahir et al., 2010). The initial STOPP tool included 65 criteria
which was recently increased to 87 with the publication of the STOPP/START criteria version
two developed in 2014. The STOPP/START tool version two also considers the risk of
prescriptions in the presence of renal impairment defined by serum creatinine and an estimated
glomerular filtration rate (Corsonello et al., 2012; Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).
The START tool was developed to address omission errors commonly seen within the geriatric
population. This included medications that were frequently omitted due to irrational reasons but
are found to be beneficial to patients in this population (Corsonello et al., 2012). The START
tool initially included 22 criteria but has most recently increased to 35 with an inclusion of
appropriate vaccinations (Vélez-Díaz-Pallarés & Cruz-Jentoft, 2014).
Since its first publication, the STOPP/START criteria has been heavily researched. In
fact, there have been 74 published articles describing its use since 2008 which have been applied
to various clinical settings in over 24 countries. Through a multitude of research articles, the
STOPP/START clinical tool has continuously proven to be valid and demonstrated a high inter
rater reliability (Cahir et al., 2010; O'Mahony et al., 2015). Thus, this tool is thought to be
applicable in multiple settings and on an international scale.
Prevalence of PIP Identified Using STOPP/START
Prior to analyzing the impact that such a tool has on health outcomes, there needs to be an
evaluation of the tool and if it accurately detects PIP. A majority of the evaluations of the
STOPP/START criteria tool are based on version one as version two has only recently been
deployed.
An observational cross sectional study was completed in Spain in a primary care setting.
A total of 272 electronic health records were audited and assessed using the STOPP/START
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criteria. The population was patients over the age of 65 with at least one medication prescribed
within the last three months and a mean number of five medications per patients. The study
found a prevalence of misprescribing and overprescribing using STOPP version one at a rate of
37.5% and using version two at 50.7%. The prevalence of underprescribing using START
version one at a rate of 45.9% and using version two at 43.0%. The most prevalent medication
identified using the STOPP criteria was proton pump inhibitors (PPI) without indication. The
most prevalent START medications identified were lack of a prescribed calcium and vitamin D
supplement in patients with osteoporosis and lack of antiplatelet therapy in diabetic patients with
coexisting cardiovascular risk factors (Castillo-Paramo et al., 2014).
A cross sectional study was completed in a 975 bed teaching hospital in Belgium over a
12-month period, between the years 2007 and 2008. This study focused on frail elders who were
over the age 75 and were admitted to the hospital with an acute illness; a total of 302 subjects
with 2,028 medications were included in the study. Data was collected via electronic health
records and assessed using the STOPP/START criteria. When using the STOPP criteria, the
researchers found 210 events of PIP. They found that 144 of the 302 frail elders were prescribed
inappropriate medications with a prevalence of 47.7%. The five most frequently inappropriate
medications prescribed were benzodiazepines, aspirin, opiates, beta blockers, and tricyclic
antidepressants. START criteria identified 362 events of potential prescribing omissions (PPO).
They found 190 of the 302 frail elders had events of PPO with a prevalence of 62.9%. The most
frequently omitted medications were aspirin, statins, metformin, calcium, vitamin D,
bisphosphonates, warfarin, and bronchodilators (Dalleur et al., 2012).
A systematic review was completed which included 12 observational studies and one
randomized controlled trial (the aforementioned studies were not included in this systematic
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review) to assess the sensitivity of the STOPP/START criteria. The review found that the
prevalence of patients with at least one incidence of PIP ranged from 21.4% to 79%. They
outlined that the most commonly encountered PIP medications were PPIs at full therapeutic
dosage for longer than eight weeks, use of long acting benzodiazepines for longer than one
month, and use of neuroleptics as hypnotics for longer than one month. The prevalence of PPO
ranged from 22.7% to 74%. The most encountered PPO medications were calcium with vitamin
D in patients with osteoporosis, statin therapy with documentation of coronary, cerebral, or
peripheral vascular disease with a life expectancy longer than five years, and statin therapy in
patients with diabetes with an elevated cholesterol or additional cardiovascular risks (Hill-Taylor
et al., 2013).
Reducing Health Care Outcomes
Potentially inappropriate prescribing is associated with an array of medical consequences.
Polypharmacy has been associated with adverse drug reactions, non-adherence, diminished
activities of daily living and quality of life, increased health service utilization, cognitive
impairment, falls, and urinary incontinence (Shah & Hajjar, 2012). The STOPP/START criteria
tool has shown promise in reducing some of the consequences of PIP.
The cross sectional study detailed previously by Dalleur et al. (2012) found that of the
302 frail elders admitted to the hospital, 82 admissions were contributed to PIP according to the
STOPP/START criteria. Of the 302 admission, 54 were related to inappropriately prescribed
medications. Of the 54, 46 admissions involved a fall with a major fracture. Additionally, of the
46 patients there were 66 inappropriate medications prescribed which included benzodiazepines
(35), opiates (13), neuroleptics (12), and antihistamines (2). PPOs were related to 38 of the 302
admissions. These data suggest that 25% of the patients with fall and subsequent fractures had
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not been receiving calcium with vitamin D or bisphosphonates. The study determined that acute
hospital admission was related to both inappropriate prescriptions and omissions at a rate of 18%
and 13% respectively (Dalleur et al., 2012).
A prospective study of 600 patients over the age of 65 who were admitted to a teaching
hospital over a four-month period found that a total of 329 ADRs were detected in 158 or the 600
patients. Of the 329 ADRs, 219 were considered contributory to admission. They found that
when STOPP criteria meds were prescribed the risk of ADRs increased significantly with an
odds ratio of 1.847. Two of the most significant ADRs contributing to admission were falls
while receiving benzodiazepines and symptomatic orthostasis while receiving antihypertensives
(Hamilton, Gallagher, Ryan, Byrne, & O'Mahony, 2011).
Perhaps the most convincing evidence comes from a randomized controlled trial (RCT)
conducted by Gallagher, O’Conner, and O’Mahony (2011) which evaluated 400 hospitalized
patients over the age 65. Patients were evaluated using the STOPP/START criteria and
recommendations were given to the care giving team. The medications were assessed for
appropriateness using the Medication Appropriateness Index (MAI) and the Assessment of
Underutilization Index at the time of discharge and six months’ post discharge. The study found
that unnecessary polypharmacy, the use of incorrect dosages, and potential drug-drug, and drug
disease interactions significantly lowered in the intervention group at the time of discharge.
More specifically, the absolute risk reduction was 35.7% within the intervention group.
Furthermore, the prevalence of falls and all-cause mortality was lower in the intervention group
although the differences in both groups was not statistically significant. The study also
concluded that the intervention group had a lower frequency of primary care visits within the sixmonth period (Gallagher, O'Connor, & O'Mahony, 2011; Hill-Taylor et al., 2013).
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Comparing STOPP/START to Beer’s
Much of the literature in comparing the STOPP/START criteria and the Beer’s criteria is
outdated due to the fact that both criterion tools have been recently updated. The
STOPP/START criteria was updated in 2014 while there was a revision to the Beer’s criteria in
2012 (Oliveira et al., 2015). Thus, the information following must be scrutinized due to the lack
of updated evidence.
Initial literature had determined that the STOPP criteria version one was much more
sensitive than the Beer’s criteria from 2003. Studies suggested that the STOPP/START criteria
were able to detect up to 91% of ADR medications while only 48% were detected by the Beer’s
criteria. Furthermore, evidence revealed that medications listed on the STOPP/START criteria
significantly increased ADRs and that the medications listed on the Beer’s Criteria showed no
association with increased risk to ADRs (Corsonello et al., 2012). The significance of difference
between the tools have lessened with the updated version of the Beer’s Criteria.
A retrospective cohort study which evaluated medical records of nursing home patients
over 65 compared the STOPP/START criteria to the newest version of the Beer’s Criteria. The
study concluded that due to the patient population and the incidence of sedative medications the
Beer’s criteria identified more incidents of inappropriate prescribing. However, they determined
that both sets of criteria identified largely the same patients and that there was no difference in
the risk of adverse outcomes (Grace et al., 2014).
A prospective survey was completed on 142 patients 60 years and older within a primary
care setting in Brazil. The research indicated that 33.8% of PIP was identified using the STOPP
criteria while 51.8% were identified using the 2012 Beer’s Criteria. The study also compared
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results using the 2003 Beer’s Criteria which revealed that 34.5% of PIP was identified (Oliveira
et al., 2015).
The conclusion that one tool is more sensitive or specific than the latter is difficult to
determine. Several studies produce differing results but specific factors must be considered prior
to forming a conclusion. Specific factors that may influence the results include which country
the research was completed and the healthcare setting (Oliveira et al., 2015). Additionally, in
order for these tools to remain clinically relevant and valid they must be frequently updated, thus
comparing frequently updated versions has proven to be challenging.
Critical Analysis of Literature
The evidence that was extracted from the literature was ranked using the Oxford Centre
of Evidence Based Medicine (OCEBM). The OCEBM was designed to assist clinicians to make
quick and accurate decisions when confronted with clinical questions. The OCEBM allows
clinicians and patients to praise evidence on therapeutic effects and harms as well as prevalence,
accuracy of diagnostic tests, prognosis, therapeutic effects, rare and common harms, and
usefulness of screening (Howick et al., 2011). This particular grading system provides a scale
from one to five for rating evidence from strongest to weakest using quality of study design and
susceptibility to bias (OCEBM Levels of Evidence Working Group, 2011). The author chose to
use the OCEBM scale to rank the evidence as this grading system is straightforward and easy to
follow.
The first question to address is whether the STOPP/START criteria is able to detect PIP
as it was designed. The OCEBM tool to evaluate the literature would rank the articles at Level 1
and Level 3. Giving a grade B recommendation based on the consistency of the levels of
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evidence (Centre for Evidence-Based Medicine, 2009). Concluding that the STOPP/START
criteria does in fact detect PIP.
Literature was reviewed to determine if the STOPP/START criteria reducing health care
outcomes. The level of evidence for this topic would include Level 1, Level 2, and Level 3
based on the OCEBM tool, thus giving the evidence a grade B (Centre for Evidence-Based
Medicine, 2009). The author would conclude that evidence suggested that this explicit criteria
tool does have the capability of reducing health care outcomes in the elderly population.
The literature review also included information comparing the STOPP/START criteria
with the Beer’s Criteria. The level of evidence of the articles were consistently Level 3 which
would give the recommendation a grade B but the conclusion that one method is more clinically
applicable than the other is much more difficult to determine (Centre for Evidence-Based
Medicine, 2009). As previously stated, both tools have been recently updated and very little
literature exists that compares both updated explicit criteria tools. Therefore, the argument of
using the STOPP/START tool over the Beer’s criteria would rest on the conclusion that the
STOPP/START tool is easier to apply in clinical practice. The STOPP/START tool is organized
according to physiological systems and medications are listed per class which enhances both its
usability and transferability (Hill-Taylor et al., 2013). Thus, the STOPP/START tools
organization makes it easy to apply in clinical practice even for a novice practitioner.
The author must note that the STOPP/START criteria was developed to be more
applicable in European countries while the Beer’s criteria was developed to be used in the United
States. Very few studies researched the impact of the STOPP/START criteria in the United
States thus a determination that this criterion would be more applicable with the American
population is inconclusive. Additionally, it was noted that many of the research studies were
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conducted by the same authors that developed the original STOPP/START criteria which would
question the possibility of bias.
Applying the STOPP/START Criteria to the Case Report
The STOPP/START criteria version two was applied to the detailed case report to
determine if there were any associated PIP occurrences. The first step in the evaluation would be
to determine if the patient had an indication for her prescribed medications, if any medications
were prescribed beyond their recommendation, or if there were any duplicate class prescriptions.
Evaluation reveals that the patient did have an indication for all prescribed meds, there was no
medications that were prescribed beyond their recommendation such as PPIs, and there were no
duplicate class prescriptions.
As stated previously in the case report, the patient presented with symptoms of
hypotension and bradycardia which was a direct result of her prescribed beta blocker
(Metoprolol). The STOPP criteria details that a beta blocker should be discontinued with a pulse
less than 50 bpm. The pulse rate of the patient was 50 bpm and she was symptomatic thus the
decision to reduce this medication would be supported. Additionally, the criteria state that beta
blockers should not be used in patients with diabetes mellitus who suffer from frequent
hypoglycemic episodes. Although hypoglycemia was not found in the patient assessment, it
would be worthy to note follow up blood glucose levels. The criteria also indicate that
acetylcholinesterase inhibitors should be withdrawn with a known history of persistent
bradycardia. A detailed record of the patient’s previous pulse rates was not provided but should
be evaluated in the future to determine if this medication should be continued based on her vital
signs.

REDUCING PIP USING STOPP/START TOOL

19

Further review of the criteria and medication list resulted in drugs that should be
discontinued according to the STOPP criteria if the listed reactions arise. The patient is on an
angiotensin receptor blocker (Losartan) which should be discontinued in patients with
hyperkalemia. E.S. is also taking a selective serotonin re-uptake inhibitor (Paroxetine) which
should be discontinued in the presence of hyponatremia. The patient is also taking a neuroleptic
antipsychotic (Quetiapine) which should not be prescribed in the presence of Parkinson’s or
Lewy Body disease. As stated, the patient is not currently presenting with the symptoms or lab
values which would indicate a discontinuation of these medications but further monitoring would
be warranted.
Finally, the medication and diagnosis list was compared to the START criteria. The
evaluation revealed that the patient was already on all of the recommended medications based on
her diagnosis list. The meds include an inhaled beta 2 agonist and inhaled corticosteroid for
COPD, an acetylcholinesterase inhibitor for mild to moderate dementia, and an angiotensin
receptor blocker with diabetes. Other considerations for follow up would be the
recommendation for her influenza and pneumococcal vaccinations. The patient does not have a
history of osteoporosis listed but it would be recommended that a calcium/vitamin D supplement
or bisphosphonate be initiated in the presence of a diagnosis. Thus, an evaluation of the need for
a Dexa scan should be considered. Additionally, a vitamin D supplement is recommended if the
patient becomes home bound.
After review of the patient’s case using the STOPP/START criteria the author would
conclude that the tool is helpful in guiding the patient’s treatment plan. The tool was very
straightforward and easy to follow which makes it clinically applicable. The 2012 Beer’s criteria
was also evaluated and was found to be beneficial. The Beer’s criteria was more difficult to
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evaluate based on the patient’s medications and history but with persistent use it would prove to
be as beneficial as the STOPP/START criteria. Furthermore, the author would conclude that
using the STOPP/START criteria would not have prevented the patient’s hospitalization but may
prevent further adverse health outcomes due to ADRs.
Conclusion
Over the next 25 years, the portion of the population over the age of 65 in the United
States is expected to double and exceed 89 million by the year 2050 (Centers for Disease Control
and Prevention (CDC), 2013). If life expectancy continues to increase as projected, there will be
a correlated increase in the prevalence of chronic conditions. With a lack of evidence to support
the use of guidelines in this population, providers need additional tools to assist in their
prescription practices. The START/STOPP criteria has proven to be a valid tool that is reliable
and results in outcomes that increase the identification of PIP as well as decreasing adverse
health outcomes related to prescription medications. Thus, using the STOPP/START criteria in
addition to clinical assessment and judgement shows promise in enhancing the geriatric patient’s
quality of life.





Learning Points

Medication review to detect PIP is imperative in older adults to reduce adverse health
outcomes related to medication overuse, misuse, and underuse
The STOPP/START criteria has proven to be a valid and reliable tool in detecting PIP
The STOPP/START criteria can reduce adverse health care outcomes by addressing PIP
The use of explicit tools such as the STOPP/START criteria and the Beer’s criteria are
meant to be a supplementation to provider’s prescriptive practices
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